Data as of Jul 29
| +0.01 / +0.04%|
The 9 analysts offering 12-month price forecasts for Imperva Inc have a median target of 34.00, with a high estimate of 62.00 and a low estimate of 25.00. The median estimate represents a +49.58% increase from the last price of 22.73.
The current consensus among 12 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.